Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085625 · ClinicalTrials.gov registry record · Phase 2
A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy
A Phase 2 study of Thyroid Lobectomy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 224
- Enrollment target
- 1
- Study location
NCT06085625: Recruiting Phase 2 study of Thyroid Lobectomy, sponsored by M.D. Anderson Cancer Center.
NCT06085625 is a Phase 2 study of Thyroid Lobectomy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 224 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06085625, a Phase 2 study of Thyroid Lobectomy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 224 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
Conditions Studied
Interventions
- BEHAVIORAL Pre-Surgery Survey
- BEHAVIORAL Post-Surgery Surveys
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2024-11-26 |
| Est. Completion | 2027-11-01 |
| Phase | Phase 2 |
What NCT06085625 shows while recruiting
NCT06085625 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher).
The record links to 1 condition, with Thyroid Lobectomy appearing as the primary indexed condition, and to 2 interventions - of which Pre-Surgery Survey is the first listed.
NCT06085625 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06085625 about?
NCT06085625 is a clinical study titled "A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy". To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
What is the current status of trial NCT06085625?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 224 participants. The study started on 2024-11-26. Estimated completion is 2027-11-01.
What conditions does trial NCT06085625 study?
This clinical trial studies the following conditions: Thyroid Lobectomy.
What interventions are being tested in trial NCT06085625?
The interventions under investigation include: Pre-Surgery Survey (BEHAVIORAL), Post-Surgery Surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT06085625?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06085625 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06085625's enrollment target sits among peer trials
224 269th of 2000 higher than 1,728 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI